We use cookies to give you the best online experience. By using our website you agree to our use of cookies in accordance with our cookie policy. Learn more OK
Menu Search : Media

You are here:

  1. Media
  • Home
  • About Roche
  • Therapy Areas
  • Safety, Health and Wellbeing
  • Media
  • Social Value
  • Careers
  • Contact Us
banner

Roche Stories

Company Statement: Delhi High Court Interim Order, March 03, 2017

An Opportunity for India: Improving Transparency

Providing confidence and support to patients

Approval of biosimilars must be subject to rigorous clinical and regulatory standards.

Media Relations

Our aim is to provide news media with clear, accurate and timely information about our pharmaceutical products, services and business activities.

Media Release

Roche’s Atezolizumab receives DCGI approval for treatment of extensive-stage small cell lung cancer in India

Roche launches new therapy Emicizumab for people with Hemophilia A on World Hemophilia Day

Roche and St. Jude India ChildCare Centre come together with Dr. B Barooah Cancer Institute to offer holistic cancer care to underprivileged children

Roche Pharma India partners with Cipla to create greater access to key medicines

Media Enquiries

For media enquiries, please contact:
Tel: +91 (22) 33941017
Email: harsh.sheth@roche.com

 

Share
  • Share via email
  • Share on Facebook
  • Share on Twitter
  • Share on LinkedIn
  • Share on Google+
  • Share on Xing
Close
  • © 2020
  • 25.03.2020
  • Legal Statement
  • Privacy Policy

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.